<DOC>
	<DOCNO>NCT02784327</DOCNO>
	<brief_summary>PRF110 new extend release oily solution formulation ropivacaine intend local infiltration surgical wound . The purpose study determine safety early efficacy PRF110 bunionectomy surgery , measure pharmacokinetic profile PRF110 72 hour evaluate duration analgesia witness surgical setting .</brief_summary>
	<brief_title>A Study Evaluate Safety , Pharmacokinetics Preliminary Efficacy PRF110 Bunionectomy Surgery</brief_title>
	<detailed_description>PRF110 new extend release oily solution formulation ropivacaine intend local infiltration surgical wound . The formulation design slowly release ropivacaine 36-72 hour . By provide local analgesia long time span , need systemic analgesic expect reduced . The purpose study determine safety early efficacy PRF110 bunionectomy surgery , measure pharmacokinetic profile PRF110 72 hour evaluate duration analgesia witness surgical setting .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>1 . Able provide write informed consent prior study procedure ; 2 . Able communicate clearly Investigators study staff ; 3 . Males female age 18 85 year age ; 4 . Scheduled elective primary unilateral first metatarsal bunionectomy surgery ( osteotomy internal fixation ) collateral procedure ; 5 . Females must physically incapable childbearing potential ( postmenopausal least 2 year surgically sterile ) practice acceptable method contraception ( hormonal , barrier spermicide , intrauterine device , vasectomized partner , abstinence ) . Subjects use hormonal birth control must receive least 1 cycle treatment prior study drug administration . At Baseline , females childbearing potential must negative pregnancy test breast feeding ; 6 . Negative urine drug screen drug abuse Screening Day 1 prior surgery ; positive drug screen result may permit subject stable dose allow medication &gt; 30 day ( antipsychotic , antiepileptic , sedative , hypnotic , antianxiety agent , antidepressant ) ; 7 . American Society Anesthesiologists ( ASA ) risk class I II ; 8 . Body Mass Index â‰¤32 . 1 . Has know allergy opioid , unless subsequently tolerate opioids , opinion Investigator , could tolerate rescue drug contain fentanyl ; 2 . Has know suspect allergy paracetamol , ibuprofen dipyrone ; 3 . Has know suspect allergy local anesthetic ; 4 . Has atrial fibrillation/flutter , insert pacemaker , complete leave bundle branch block ( LBBB ) ECG ; myocardial infarction within 6 month prior surgery ; 5 . Has clinically significant abnormal ECG screening ; 6 . Has know suspect history diagnose alcohol , opiate substance abuse within 12 month prior screen ; 7 . Is unable refrain alcohol consumption period begin 24 hour prior surgery end 72 hour evaluation period ; 8 . Has take analgesic within 12 hour aspirincontaining product within 7 day Baseline assessment ; 9 . Has take opioid analgesic use systemic steroid within 4 day surgery ; 10 . Has use opiate nonsteroidal antiinflammatory drug chronically ( 10 consecutive day ) anytime past 3 month ; 11 . Has use antipsychotic , antiepileptic , sedative , hypnotic , antianxiety agent antidepressant &lt; 30 day prior surgery dose change within previous 30 day ; 12 . Has take prescription overthecounter medication within 4 day prior surgery , opinion Investigator , could potentially confound analgesic response ; 13 . Has take herbal agent nutraceuticals 7 day prior surgery , opinion Investigator , could potentially confound analgesic response ; 14 . Has clinically significant condition significant laboratory abnormality would , opinion Investigator , preclude study participation ; 15 . Unable unwilling , opinion Investigator comply requirement protocol ; 16 . Has receive another investigational drug within 30 day schedule surgery ; 17 . Has donate blood within three month prior start study ; 18 . Employees Investigator study site sponsor , well family member employee investigator sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>